Investor's Business Daily on MSN12m
Novo Nordisk Dives After Medicare Targets Ozempic, Wegovy For Price CutsNovo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.
Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback